{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:57Z","timestamp":1786119657076,"version":"build-2736575974"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/ftd.0b013e31820c0a96","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T08:13:24Z","timestamp":1299312804000},"page":"155-164","source":"Crossref","is-referenced-by-count":17,"title":["How Delayed Graft Function Impacts Exposure to Mycophenolic Acid in Patients After Renal Transplantation"],"prefix":"10.1097","volume":"33","author":[{"given":"Teun","family":"van Gelder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helio Tedesco","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"de Fijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D","family":"Mamelok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor W","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Oellerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210129","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1600-6143.2006.01270.x","article-title":"Immunosuppression: evolution in practice and trends, 1994-2004.","volume":"6","author":"Meier-Kriesche","year":"2006","journal-title":"Am J Transplant"},{"key":"R2-4-20210129","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1034\/j.1600-6143.2003.00079.x","article-title":"Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies.","volume":"3","author":"Shaw","year":"2003","journal-title":"Am J Transplant"},{"key":"R3-4-20210129","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1097\/01.ASN.0000087540.41388.AD","article-title":"Immunosuppression with mycophenolic acid: one size does not fit all.","volume":"14","author":"Bennett","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R4-4-20210129","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-6143.2005.00793.x","article-title":"Mycophenolate mofetil: how to further improve using an already successful drug?","volume":"5","author":"Van Gelder","year":"2005","journal-title":"Am J Transplant"},{"key":"R5-4-20210129","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1681\/ASN.2005101070","article-title":"Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.","volume":"17","author":"Van Hest","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R6-4-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2125.2006.02841.x","article-title":"Time-dependent clearance of mycophenolic acid in renal transplant recipients.","volume":"63","author":"Van Hest","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"R7-4-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","article-title":"Clinical pharmacokinetics of mycophenolate mofetil.","volume":"34","author":"Bullingham","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"R8-4-20210129","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2165\/00003088-200544100-00006","article-title":"Population pharmacokinetics of mycophenolic acid in renal transplant recipients.","volume":"44","author":"Van Hest","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R9-4-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2125.2004.02235.x","article-title":"Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.","volume":"59","author":"Atcheson","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"R10-4-20210129","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/j.1552-4604.2000.tb05988.x","article-title":"Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable.","volume":"40","author":"Shaw","year":"2000","journal-title":"J Clin Pharmacol"},{"key":"R11-4-20210129","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1097\/00007890-199905150-00005","article-title":"Predictors of renal transplant histology at three months.","volume":"67","author":"Kuypers","year":"1999","journal-title":"Transplantation"},{"key":"R12-4-20210129","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0b013e318186f98a","article-title":"comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the Fixed-Dose Concentration-Controlled (FDCC) Trial.","volume":"86","author":"van Gelder","year":"2008","journal-title":"Transplantation"},{"key":"R13-4-20210129","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/clinchem\/48.9.1497","article-title":"Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus.","volume":"48","author":"Pawinski","year":"2002","journal-title":"Clin Chem"},{"key":"R14-4-20210129","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00007691-200004000-00005","article-title":"Limited sampling strategy for mycophenolic acid area under the curve.","volume":"22","author":"Filler","year":"2000","journal-title":"Ther Drug Monitor"},{"key":"R15-4-20210129","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.ftd.0000246766.12872.12","article-title":"Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients.","volume":"28","author":"Weber","year":"2006","journal-title":"Ther Drug Monitor"},{"key":"R16-4-20210129","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology.","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"R17-4-20210129","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1093\/clinchem\/44.7.1481","article-title":"Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure.","volume":"44","author":"Shipkova","year":"1998","journal-title":"Clin Chem"},{"key":"R18-4-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1373\/clinchem.2003.024323","article-title":"Validation of a rapid and sensitive liquid chromatography-tandem mass spectrometry method for free and total mycophenolic acid.","volume":"50","author":"Streit","year":"2004","journal-title":"Clin Chem"},{"key":"R19-4-20210129","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/ndt\/gfl042","article-title":"Major effects of delayed graft function and cold ischaemia time on renal allograft survival.","volume":"21","author":"Quiroga","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R20-4-20210129","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1111\/j.1600-6143.2005.01090.x","article-title":"Multivariate analysis of risk factors for acute rejection in early corticosteroid cessation regimens under modern immunosuppression.","volume":"5","author":"Woodle","year":"2005","journal-title":"Am J Transplant"},{"key":"R21-4-20210129","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1600-6143.2004.00455.x","article-title":"Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation.","volume":"4","author":"Kiberd","year":"2004","journal-title":"Am J Transplant"},{"key":"R22-4-20210129","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0009-9236(98)90058-3","article-title":"The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation.","volume":"64","author":"Hale","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R23-4-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/clinchem\/41.7.1011","article-title":"Mycophenolic acid binding to human serum albumin: characterization and relation to pharmacodynamics.","volume":"41","author":"Nowak","year":"1995","journal-title":"Clin Chem"},{"key":"R24-4-20210129","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1681\/ASN.V133759","article-title":"The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the German study group on mycophenolate mofetil therapy.","volume":"13","author":"Weber","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"Suppl","key":"R25-4-20210129","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1097\/01.tp.0000186380.61251.fc","article-title":"The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation.","volume":"80","author":"Van Gelder","year":"2005","journal-title":"Transplantation"},{"key":"R26-4-20210129","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1177\/00912709922008353","article-title":"The effect of renal insufficiency on mycophenolic acid protein binding.","volume":"39","author":"Kaplan","year":"1999","journal-title":"J Clin Pharmacol"},{"key":"R27-4-20210129","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/00007890-199804270-00019","article-title":"Decreased protein binding of mycophenolic acid associated with leukopenia in a pancreas transplant recipient with renal failure.","volume":"65","author":"Kaplan","year":"1998","journal-title":"Transplantation"},{"key":"R28-4-20210129","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1681\/ASN.V981511","article-title":"Pharmacokinetics of mycophenolic acid (MPA) and determinants of MPA free fraction in pediatric and adult renal transplant recipients. German Study group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients.","volume":"9","author":"Weber","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R29-4-20210129","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/j.1552-4604.1998.tb04424.x","article-title":"Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function.","volume":"38","author":"Shaw","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"R30-4-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2125.2004.02235.x","article-title":"Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.","volume":"59","author":"Atcheson","year":"2005","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl 1","key":"R31-4-20210129","doi-asserted-by":"crossref","first-page":"S308","DOI":"10.1111\/j.1432-2277.1996.tb01637.x","article-title":"Mycophenolate mofetil in patients with acute renal failure: evidence of metabolite (MPAG) accumulation and removal by dialysis.","volume":"9","author":"Zanker","year":"1996","journal-title":"Transpl Int"},{"key":"R32-4-20210129","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0009-9236(98)90102-3","article-title":"The pharmacokinetics of a single oral dose of mycophenolate mofetil in patients with varying degrees of renal function.","volume":"63","author":"Johnson","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"R33-4-20210129","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00007691-199812000-00019","article-title":"Evaluation of an immunoassay (EMIT) for mycophenolic acid in plasma from renal transplant recipients compared with a high-performance liquid chromatography assay.","volume":"20","author":"Beal","year":"1998","journal-title":"Ther Drug Monit"},{"key":"R34-4-20210129","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0041-1345(98)01936-8","article-title":"Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite.","volume":"31","author":"Shipkova","year":"1999","journal-title":"Transplant Proc"},{"key":"R35-4-20210129","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/clinchem\/48.3.517","article-title":"Comparison of the Emit immunoassay with HPLC for therapeutic drug monitoring of mycophenolic acid in pediatric renal-transplant recipients on mycophenolate mofetil therapy.","volume":"48","author":"Weber","year":"2002","journal-title":"Clin Chem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0b013e31820c0a96","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:46:01Z","timestamp":1786041961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-201104000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31820c0a96","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}